In January-September 2011, Biofarm posted a net profit of RON13.75 million.
The company reported sales of RON77.2 million in the first nine months, 15% higher from RON67.2 million in the year-ago period.
Overall revenue rose 13.8% on the year to RON84.3, while total expenditure was up 9.2% to RON61 million.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
The company estimates a net profit of RON16.6 million in 2012, 17% higher on the year.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
On the Bucharest bourse Wednesday, Biofarm closed down 1.49% at RON0.1921 a share, amid a slightly declining market. (EUR1=RON4.5388)